CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 145 enrolled
Drug / intervention
Paragastric autonomic neural blockadeprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05353426
NCT05353426N/ACompleted
CompareCT.gov

Paragastric Lesser Omentum Neural Block to Prevent Visceral Pain After Laparoscopic Sleeve Gastrectomy: A Randomized Clinical Trial Protocol.

Universidad Simón Bolívar·interventional·Posted Apr 29, 2022·Updated Apr 29, 2022

In Brief

A clinical study evaluating Paragastric autonomic neural blockade for Visceral Pain and 4 related conditions. Completed, enrolled 145 participants across 1 site.

Detailed Summary

Visceral pain (VP) following laparoscopic sleeve gastrectomy remains a substantial problem. VP is associated with autonomic symptoms, especially nausea and vomiting, and is unresponsive to traditional pain management algorithms aimed at alleviating somatic (incisional) pain. The present study was performed to evaluate the safety and effectiveness of laparoscopic paragastric autonomic neural blockade (PG-ANB) in managing the symptoms associated with VP following sleeve gastrectomy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisceral Pain, Bariatric Surgery Candidate, Pain, Postoperative, Vomiting, Postoperative, Nausea, Postoperative
CountriesColombia
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedApr 29, 2022
Enrollment StartAug 13, 2021
Primary CompletionFeb 3, 2022
Study CompletionMar 21, 2022
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 4.2 years ago

Interventions

Paragastric autonomic neural blockadeprocedure

Paragastric autonomic neural blockade with Bupivacaine